PubRank

David Binns

Author PubWeight™ 189.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 InterPro: the integrative protein signature database. Nucleic Acids Res 2008 25.07
2 The InterPro Database, 2003 brings increased coverage and new features. Nucleic Acids Res 2003 24.72
3 The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res 2004 18.75
4 InterPro, progress and status in 2005. Nucleic Acids Res 2005 17.53
5 InterPro in 2011: new developments in the family and domain prediction database. Nucleic Acids Res 2011 13.45
6 The Gene Ontology Annotation (GOA) project: implementation of GO in SWISS-PROT, TrEMBL, and InterPro. Genome Res 2003 12.81
7 New developments in the InterPro database. Nucleic Acids Res 2007 12.49
8 UniProt archive. Bioinformatics 2004 11.92
9 The GOA database in 2009--an integrated Gene Ontology Annotation resource. Nucleic Acids Res 2008 10.21
10 InterProScan 5: genome-scale protein function classification. Bioinformatics 2014 8.52
11 An evaluation of GO annotation retrieval for BioCreAtIvE and GOA. BMC Bioinformatics 2005 6.58
12 Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006 2.68
13 InterPro: an integrated documentation resource for protein families, domains and functional sites. Brief Bioinform 2002 2.66
14 The InterPro BioMart: federated query and web service access to the InterPro Resource. Database (Oxford) 2011 1.75
15 A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 2006 1.73
16 Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation. Int J Radiat Oncol Biol Phys 2004 1.64
17 Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009 1.21
18 Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis. Int J Radiat Oncol Biol Phys 2010 1.20
19 Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice. Acta Oncol 2002 1.19
20 The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer. Radiother Oncol 2013 1.13
21 The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002 1.08
22 Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results. J Pharm Pharm Sci 2007 1.04
23 An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development. Cancer Res 2005 1.02
24 Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033. Eur J Nucl Med Mol Imaging 2006 1.01
25 QuickGO: a user tutorial for the web-based Gene Ontology browser. Database (Oxford) 2009 1.01
26 Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging 2005 0.99
27 Progressive metabolic and structural cerebral perturbations after traumatic brain injury: an in vivo imaging study in the rat. J Nucl Med 2010 0.96
28 High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer. Cancer 2010 0.92
29 Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE. Epilepsia 2012 0.92
30 Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging. Mol Cancer Ther 2005 0.91
31 Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume. Int J Radiat Oncol Biol Phys 2013 0.89
32 PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate. Dalton Trans 2013 0.88
33 Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models. J Nucl Med 2011 0.87
34 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy. J Nucl Med 2013 0.84
35 Diagnostic imaging agents for Alzheimer's disease: copper radiopharmaceuticals that target Aβ plaques. J Am Chem Soc 2013 0.82
36 High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT. Eur J Nucl Med Mol Imaging 2013 0.81
37 Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer. J Med Imaging Radiat Oncol 2014 0.80
38 Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy. J Med Imaging Radiat Oncol 2013 0.79
39 In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat. Eur J Nucl Med Mol Imaging 2009 0.79
40 The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data. Radiother Oncol 2013 0.77
41 Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer. J Nucl Med 2012 0.77
42 Pulmonary tumor volume delineation in PET images using deformable models. Conf Proc IEEE Eng Med Biol Soc 2008 0.76
43 β-[18F]Fluoro Azomycin Arabinoside (β-[18F]FAZA): Synthesis, radiofluorination and preliminary PET imaging of murine A431 tumors. Curr Radiopharm 2017 0.75
44 Scatter limitation to correct for arm movement in PET/CT. Clin Nucl Med 2012 0.75
45 F-18 PET soft tissue uptake in seatbelt injury. Clin Nucl Med 2004 0.75
46 Automatic tumour volume delineation in respiratory-gated PET images. J Med Imaging Radiat Oncol 2011 0.75